21 – 25 of 35
- show: 5
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2012
-
Mark
Imatinib after induction for treatment of children and adolescents with Philadelphia-chromosome-positive acute lymphoblastic leukaemia (EsPhALL): a randomised, open-label, intergroup study
(
- Contribution to journal › Article
-
Mark
Vandetanib in locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 2 trial
(
- Contribution to journal › Article
-
Mark
Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies
(
- Contribution to journal › Article
-
Mark
Cancer incidence in patients with polyglutamine diseases: a population-based study in Sweden.
(
- Contribution to journal › Article
- 2010
-
Mark
Risk of thromboembolic diseases in men with prostate cancer: results from the population-based PCBaSe Sweden
(
- Contribution to journal › Article